Zobrazeno 1 - 10
of 227
pro vyhledávání: '"R. Massaad"'
Publikováno v:
Osteoporosis International. 33:2165-2175
Autor:
D. Lorusso, N. Colombo, A. Casado Herraez, A.D. Santin, E. Colomba, D.S. Miller, K. Fujiwara, S. Pignata, S.E. Baron-Hay, I.L. Ray-Coquard, R. Shapira-Frommer, Y.M. Kim, M. McCormack, R. Massaad, A. Martin Nguyen, Q. Zhao, J. McKenzie, V.S. Prabhu, V. Makker
Publikováno v:
Annals of Oncology. 33:S391-S392
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 33(10)
This post hoc analysis and modeling study examined the mechanism of action of odanacatib using a statistical model to explain sCTx response in ODN-treated patients as a function of other bone-turnover biomarkers that, with other observed biomarker ch
Publikováno v:
Advances in Horticultural Science, Vol 25, Iss 4 (2013)
A two-year experiment (2004-2005) was conducted at Tal Amara Research Station in the Bekaa Valley of Lebanon to evaluate the influence of progressive application of K rates and application timing on yield, yield components and tuber quality of potato
Externí odkaz:
https://doaj.org/article/3ac78b4a61d845b58aad5e69045aac30
Publikováno v:
Acta Horticulturae. :529-534
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Massaad, Shahnaz Shahinfar, Nicholas J. A. Webb, Chun Lam, Christine McCrary Sisk, Gilbert W. Gleim, Emanuela P. Santoro, Thomas G. Wells
Publikováno v:
Kidney International. 82:819-826
Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers delay progression of chronic kidney disease and have antiproteinuric effects beyond their effects on blood pressure. They are routinely used in adults; however, thei
Autor:
K. Vandormael, R. Massaad, Philippe Brudi, J.P. Reckless, T. Pomykaj, D.P. Henry, S.T. Lim, Amy O. Johnson-Levonas
Publikováno v:
Cardiology. 113:89-97
Objective: The aim of the study was to compare the efficacy/safety of doubling the dose of low-, medium- and high-potency statins on lipids/lipoproteins versus ezetimibe/simvastatin (EZE/SIMVA) 10/40 mg in patients with a recent coronary event. Metho
Autor:
Philippe Brudi, C Allen, Amy O. Johnson-Levonas, T. Pomykaj, K. Lis, John P. D. Reckless, R. Massaad, K. Vandormael, S.T. Lim, P. Henry
Publikováno v:
International Journal of Clinical Practice. 62:539-554
SUMMARY Background: The aim of this study was to investigate the efficacy and safety profile of switching to ezetimibe ⁄simvastatin (Eze ⁄Simva) 10 ⁄40 mg compared with doubling the statin dose upon discharge in patients taking a statin and adm